SETHURAMAN NATARAJAN (Chief Scientific Officer) sold 10.7% of their position (25.91K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $398.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001873394-26-000003
Officer· Chief Scientific Officer
Since Oct 2021
-25.91K
Net shares
Net seller
$398.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−25.91K
Price / share
$15.39
Trade value
$398.81K
% of position
10.7%
5/4/2026
242.22K→216.32K
Total
Net shares
−25.91K
Net value
-$398.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | S · Sale | −25.91K | $15.39 | $398.81K | 10.7% | 242.22K | 216.32K |
| Total | −25.91K | -$398.81K | ||||||
Derivative Transactions0
No derivative transactions reported